首頁 > 雜志

Acta Pharmaceutica Sinica B(2022年12期)
藥學(xué)學(xué)報(bào)(英文版)

  • 基本信息
  • 中國藥學(xué)會(huì)藥物研究所;中國醫(yī)學(xué)科學(xué)院

    月刊

    2211-3835

  • 10-1171/R

    北京市

    英文;

    大16開

    2011

  • 出版信息
  • 醫(yī)藥衛(wèi)生科技

    藥學(xué)

    1375篇

  • 49010次

    15888次

  • 評(píng)價(jià)信息
  • 3.134

    2.569

  • CA 化學(xué)文摘(美)(2024)

    SCI 科學(xué)引文索引(美)(2024)

    JST 日本科學(xué)技術(shù)振興機(jī)構(gòu)數(shù)據(jù)庫(日)(2024)

    Pж(AJ) 文摘雜志(俄)(2020)

    CSCD 中國科學(xué)引文數(shù)據(jù)庫來源期刊(2023-2024年度)

    WJCI 科技期刊世界影響力指數(shù)報(bào)告(2023)來源期刊

    中國科技期刊卓越行動(dòng)計(jì)劃入選項(xiàng)目;中國最具國際影響力學(xué)術(shù)期刊;

目 錄

  • Research and development of Chinese anti-COVID-19 drugs
  • Small molecule-based immunomodulators for cancer therapy
  • Harnessing the cyclization strategy for new drug discovery
  • Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
  • Recent advances in bacteriophage-based therapeutics: Insight into the post-antibiotic era
  • Evolution of drug regulations and regulatory innovation for anticancer drugs in China
  • Repurposing of berbamine hydrochloride to inhibit Ebola virus by targeting viral glycoprotein
  • Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-κB/IL-6/STAT3 and JNK/PTX3 pathways
  • Highly expressed SERCA2 triggers tumor cell autophagy and is a druggable vulnerability in triple-negative breast cancer
  • Landscape of DILI-related adverse drug reaction in China Mainland
  • Fully synthetic Tn-based three-component cancer vaccine using covalently linked TLR4 ligand MPLA and iNKT cell agonist KRN-7000 as built-in adjuvant effectively protects mice from tumor development
  • Novel phthalimides regulating PD-1/PD-L1 interaction as potential immunotherapy agents
  • Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics
  • Biodegradable calcium sulfide-based nanomodulators for Hu003csubu003e2u003c/subu003eS-boosted Cau003csupu003e2+u003c/supu003e-involved synergistic cascade cancer therapy
  • Spatio-temporal delivery of both intra- and extracellular toll-like receptor agonists for enhancing antigen-specific immune responses
  • Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
  • SMIP-30, a potent and selective PPM1A inhibitor with potential to treat tuberculosis
  • Commentary: Acute psychological stress redistributed leukocytes via distinct brain circuits
  • Information for Authors
客服微信二維碼

掃碼添加客服微信

聯(lián)系客服